Search clinical trials for: hormone-receptor positive breast cancer
Total 95330 results
-
University of Alabama at BirminghamNovartis Pharmaceuticals; Tracon Pharmaceuticals Inc.Completed
-
Asan Medical CenterCompletedMetastatic Breast CancerKorea, Republic of
-
PfizerCompletedBreast CancerKorea, Republic of, United States, Spain, Germany, Ireland, Hungary, Canada, France, Italy, Russian Federation, South Africa, Ukraine
-
Dana-Farber Cancer InstituteNovartis; Beth Israel Deaconess Medical CenterCompleted
-
PfizerTerminatedInvasive Early Breast CancerRomania
-
AstraZenecaCompletedBreast CancerUnited States, South Africa, Spain, France, Netherlands, United Kingdom, Greece, Canada
-
Pravin T.P KaumayaNot yet recruitingMetastatic Breast Cancer | HER2-positive Breast Cancer | HER2-positive Gastric Cancer | Metastatic Gastrointestinal Carcinoma | EGFR OverexpressionUnited States
-
AstraZenecaNot yet recruitingMetastatic Breast CancerBrazil
-
M.D. Anderson Cancer CenterNot yet recruitingHormone Receptor-positive Human Epidermal Growth Factor 2-negative | Metastatic Invasive LObular CarcinomaUnited States
-
Institut Claudius RegaudFondation Toulouse Cancer SantéNot yet recruitingMetastatic Breast CancerFrance
-
Mayo ClinicNot yet recruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage 0 Breast Cancer AJCC v8 | Breast Adenocarcinoma | Estrogen Receptor-Positive Breast Carcinoma | Progesterone Receptor-Positive Breast CarcinomaUnited States
-
Joanna ArchRecruitingBreast Cancer | DCISUnited States
-
RemeGen Co., Ltd.Not yet recruiting
-
Mayo ClinicRecruitingMetastatic Breast Cancer | HER2-negative Breast Cancer | Hormone-receptor-positive Breast CancerUnited States
-
AstraZenecaDaiichi SankyoNot yet recruitingMetastatic Breast Cancer | HER2-positive Breast Cancer | Unresectable Breast Cancer | HER2-low Expressing Breast CancerCanada
-
MedSIRStemline Therapeutics, Inc.Not yet recruitingAdvanced Breast Cancer | ER-positive Breast Cancer | HER2-negative Breast Cancer | ESR1 Gene Mutation
-
AstraZenecaNot yet recruiting
-
The First Affiliated Hospital with Nanjing Medical...Zhejiang Cancer HospitalRecruiting
-
Washington University School of MedicineUnited States Department of Defense; Aclaris Therapeutics, Inc.Not yet recruitingHormone Receptor Positive HER-2 Negative Metastatic Breast CancerUnited States
-
Puma Biotechnology, Inc.Not yet recruitingMetastatic Breast Cancer | Recurrent Breast Cancer | Hormone Receptor Positive HER-2 Negative Breast CancerUnited States
-
Universitaire Ziekenhuizen KU LeuvenEli Lilly and Company; Kom Op Tegen Kanker; Teva PharmaRecruitingTriple Negative Breast NeoplasmsBelgium
-
Huihua XiongNot yet recruiting
-
Medical College of WisconsinNot yet recruiting
-
Huihua XiongNot yet recruiting
-
Center Eugene MarquisNot yet recruiting
-
University of ChicagoNot yet recruitingBreast Cancer | HER2-positive Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastUnited States
-
Aarhus University HospitalDanish Cancer SocietyRecruitingMetastatic Breast Cancer | Adiposity | Estrogen-receptor-positive Breast CancerDenmark
-
Fudan UniversityRecruiting
-
Fudan UniversityRecruiting
-
Fudan UniversityRecruiting
-
Li HuipingNot yet recruiting
-
Shengjing HospitalJiangsu HengRui Medicine Co., Ltd.Not yet recruitingER Positive/HER2 Low Breast CancerChina
-
Helwan UniversityNot yet recruitingMetastatic Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Hormone-receptor-positive Breast Cancer
-
Maastricht University Medical CenterNot yet recruitingBreast Cancer | Breast Neoplasms | Breast DiseasesNetherlands
-
Samsung Medical CenterRecruitingHER2-positive Breast CancerKorea, Republic of
-
European Institute of OncologyRecruitingTriple Negative Breast Cancer | HER2-positive Breast Cancer | Invasive Breast CancerItaly
-
Enliven TherapeuticsRecruitingColorectal Cancer | HER2-positive Breast Cancer | HER2-positive Gastric Cancer | HER2 Amplification | HER2 Positive Solid TumorsUnited States
-
European Institute of OncologyRecruitingMelanoma | Breast Cancer | Head and Neck Cancer | Colorectal Cancer | Lung Cancer | Lung Metastases | Liver Metastases | Urothelial CarcinomaItaly
-
Sichuan Baili Pharmaceutical Co., Ltd.Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.Not yet recruitingHER2-positive Breast CancerChina
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.RecruitingHER2-positive Breast CancerChina
-
N.N. Petrov National Medical Research Center of...RecruitingOligometastatic Disease | HER2-positive Metastatic Breast CancerRussian Federation
-
Gustave Roussy, Cancer Campus, Grand ParisDaiichi SankyoRecruitingAdvanced Breast Cancer | HER2-positive Metastatic Breast Cancer | Breast Cancer Metastatic | HER2 Low Breast CarcinomaFrance
-
Regor Pharmaceuticals Inc.RecruitingBreast Cancer | Advanced Solid TumorChina
-
European Institute of OncologyRecruitingBreast Cancer | Triple Negative Breast Cancer | HER2-positive Breast Cancer | Neoadjuvant ChemotherapyItaly
-
Henan Cancer HospitalNot yet recruitingBreast Cancer | HER2-positive Breast CancerChina
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingFirst-line Treatment | HER2-positive Metastatic Breast CancerChina
-
Regina Elena Cancer InstituteRecruiting
-
DualityBio Inc.BioNTech SERecruiting
-
NiKang Therapeutics, Inc.RecruitingSmall Cell Lung Carcinoma | Gastric Cancer | Ovarian Neoplasms | Ovarian Cancer | Solid Tumor | Endometrial Neoplasms | Triple Negative Breast Cancer | Triple Negative Breast Neoplasms | Advanced Solid Tumor | Endometrial Cancer | Small-cell Lung Cancer | Platinum-resistant Ovarian Cancer | Ovarian Carcinoma | Solid... and other conditionsUnited States